Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses

Area of Science:

• Virology
• Molecular Biology
• Genetics

Background:

• Retroviral genome reverse transcription is traditionally believed to occur after viral entry into host cells.
• Understanding the precise timing of reverse transcription is crucial for developing effective antiviral strategies.

Purpose of the Study:

• To investigate whether reverse transcription of the retroviral genome initiates within newly assembled virus particles prior to cellular entry.
• To determine if human immunodeficiency virus (HIV) and murine amphotropic retrovirus contain pre-formed DNA products.

Main Methods:

• Purification of human immunodeficiency virus (HIV) and murine amphotropic retrovirus particles.
• Detection of virus-specific DNA using polymerase chain reaction (PCR) amplification.
• Analysis of early versus late viral transcripts and sensitivity to 3'-azido-3'-deoxythymidine (zidovudine) treatment.

Main Results:

• Purified HIV preparations contained virus-specific DNA, indicating early-stage reverse transcription.
• The presence of DNA was confirmed to be from reverse transcription within virions, not cellular contamination.
• Accumulation of these DNA products was sensitive to zidovudine treatment of producer cells, further supporting intracellular transcription.

Conclusions:

• Retroviral reverse transcription likely commences within newly assembled virus particles before they infect target cells.
• All retroviruses are likely to contain partial reverse transcripts, challenging the established understanding of retroviral replication initiation.